Clinical trials
Arthritis, Rheumatoid trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
195 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 18 |
| 2006 | 7 |
| 2007 | 13 |
| 2008 | 12 |
| 2009 | 13 |
| 2010 | 14 |
| 2011 | 13 |
| 2012 | 23 |
| 2013 | 12 |
| 2014 | 7 |
| 2015 | 11 |
| 2016 | 19 |
| 2017 | 7 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 160 |
| Terminated | 25 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 29 |
| Hoffmann-La Roche | 22 |
| Bristol-Myers Squibb | 20 |
| Eli Lilly and Company | 17 |
| AbbVie | 9 |
| AstraZeneca | 7 |
| Sanofi | 7 |
| Janssen Research & Development, LLC | 5 |
| Centocor, Inc. | 4 |
| Genentech, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 195 |
| Arthritis | 15 |
| Joint Diseases | 10 |
| Musculoskeletal Diseases | 8 |
| Autoimmune Diseases | 4 |
| Inflammation | 3 |
| Rheumatic Diseases | 3 |
| Connective Tissue Diseases | 2 |
| Immune System Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
Trials
Showing 51 to 75 of 195. Each trial links to its page on Pharma Observatory.
95 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.